title: Evaluation of intraocular pressure and cataract formation following the long-term use of nasal corticosteroids.
abstract: It is possible that corticosteroids administered via nasal spray might reach ocular structures in levels sufficient to provoke an ocular hypertensive response and cause posterior subcapsular cataracts (PSCs) in susceptible individuals. In the present study, 26 patients who had undergone endoscopic sinus surgery were evaluated prospectively with respect to intraocular pressure and PSC formation following the use of nasal steroids for at least three months. Eighteen patients (69%) self-administered 200 micrograms/day of budesonide nasal spray twice daily, and eight patients (31%) self-administered 200 micrograms/day of beclomethasone dipropionate nasal spray twice daily, for a period of three to 19 months (mean 8.8 +/- 3.6 months). Ophthalmologic examination, tonometry, visual field testing and biomicroscopic studies revealed no evidence of ocular hypertension or PSCs during postoperative follow-up. We conclude that intranasal corticosteroids can be used safely for prolonged periods without increasing the risk of ocular hypertension or PSCs.
authors.affiliation: Department of Ophthalmology, Celal Bayar University Medical Faculty, Manisa, Turkey.
authors.forename: F
authors.initials: F
authors.lastname: Oztürk
authors.forename: A V
authors.initials: AV
authors.lastname: Yücetürk
authors.forename: E
authors.initials: E
authors.lastname: Kurt
authors.forename: H H
authors.initials: HH
authors.lastname: Unlü
authors.forename: S S
authors.initials: SS
authors.lastname: Ilker
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001507:Beclomethasone / Q000008:administration & dosage / Q000009:adverse effects*; D019819:Budesonide / Q000008:administration & dosage / Q000009:adverse effects*; D002386:Cataract / Q000139:chemically induced* / Q000175:diagnosis; D002387:Cataract Extraction; D005260:Female; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000175:diagnosis*; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D019819:Budesonide; D001507:Beclomethasone